A new study reveals that the presence of certain bacteria in the gut may play a significant role in influencing an individual’s response to specific types of antidepressants. Researchers found that patients with higher levels of these bacteria experienced more pronounced improvements in symptoms when treated with a particular class of antidepressants. The findings suggest a potential link between gut microbiome composition and the effectiveness of medication for mood disorders. This discovery could pave the way for personalized treatment approaches based on microbial profiles.